WHO Expert Committee on Specifications for Pharmaceutical Preparations : thirty-seventh report.

Saved in:
Bibliographic Details
Superior document:WHO technical report series, 908
:
TeilnehmendeR:
Year of Publication:2003
Language:English
Series:Technical report series (World Health Organization) ; 908.
Online Access:
Physical Description:viii, 145 p.
Tags: Add Tag
No Tags, Be the first to tag this record!
id 500284793
ctrlnum (MiAaPQ)500284793
(Au-PeEL)EBL284793
(CaPaEBR)ebr10040297
(OCoLC)191039475
collection bib_alma
record_format marc
spelling WHO Expert Committee on Specifications for Pharmaceutical Preparations. Meeting (37th : 2001 : Geneva, Switzerland)
WHO Expert Committee on Specifications for Pharmaceutical Preparations [electronic resource] : thirty-seventh report.
Geneva : World Health Organization, 2003.
viii, 145 p.
WHO technical report series, 0512-3054 ; 908
1. Introduction -- 2. General policy -- 3. Quality control--specifications and tests -- 4. Quality control--international reference materials -- 5. Quality control--national laboratories -- 6. Quality assurance--good manufacturing practices (GMP) -- 7. Quality assurance--inspection -- 8. Quality assurance--distribution and trade-related -- 9. Quality assurance--risk analysis -- 10. Quality assurance--drug supply -- 11. Quality assurance--storage -- 12. International Nonproprietary Names (INNs) Programme -- 13. Miscellaneous -- Annex 1. Recommendations on risk of transmitting animal spongiform encephalopathy agents via medicinal products -- Annex 2. The International Pharmacopoeia: revised concepts and future perspectives -- Annex 3. Guidelines on good manufacturing practices for radiopharmaceutical products -- Annex 4. Good manufacturing practices for pharmaceutial products: main prinicples -- Annex 5. Model certificate of good manufacturing practices -- Annex 6. Guidance on good manufacturing practices (GMP): inspection report -- Annex 7. Application of hazard analysis and critical control point (HACCP) method to pharmaceuticals -- Annex 8. Procedure for assessing the acceptability, in principle, of pharmaceutical products for purchase by United Nations agencies -- Annex 9. Guide to good storage practices for pharmaceuticals.
Electronic reproduction. Ann Arbor, MI : ProQuest, 2015. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries.
Drugs Standards Congresses.
Drugs Specifications Congresses.
Pharmaceutical industry Quality control Congresses.
Electronic books.
ProQuest (Firm)
Technical report series (World Health Organization) ; 908.
https://ebookcentral.proquest.com/lib/oeawat/detail.action?docID=284793 Click to View
language English
format Electronic
eBook
author2 ProQuest (Firm)
author_facet ProQuest (Firm)
WHO Expert Committee on Specifications for Pharmaceutical Preparations. Meeting
ProQuest (Firm)
author2_role TeilnehmendeR
author_corporate WHO Expert Committee on Specifications for Pharmaceutical Preparations. Meeting
ProQuest (Firm)
author_sort WHO Expert Committee on Specifications for Pharmaceutical Preparations. Meeting
title WHO Expert Committee on Specifications for Pharmaceutical Preparations thirty-seventh report.
spellingShingle WHO Expert Committee on Specifications for Pharmaceutical Preparations thirty-seventh report.
WHO technical report series,
1. Introduction -- 2. General policy -- 3. Quality control--specifications and tests -- 4. Quality control--international reference materials -- 5. Quality control--national laboratories -- 6. Quality assurance--good manufacturing practices (GMP) -- 7. Quality assurance--inspection -- 8. Quality assurance--distribution and trade-related -- 9. Quality assurance--risk analysis -- 10. Quality assurance--drug supply -- 11. Quality assurance--storage -- 12. International Nonproprietary Names (INNs) Programme -- 13. Miscellaneous -- Annex 1. Recommendations on risk of transmitting animal spongiform encephalopathy agents via medicinal products -- Annex 2. The International Pharmacopoeia: revised concepts and future perspectives -- Annex 3. Guidelines on good manufacturing practices for radiopharmaceutical products -- Annex 4. Good manufacturing practices for pharmaceutial products: main prinicples -- Annex 5. Model certificate of good manufacturing practices -- Annex 6. Guidance on good manufacturing practices (GMP): inspection report -- Annex 7. Application of hazard analysis and critical control point (HACCP) method to pharmaceuticals -- Annex 8. Procedure for assessing the acceptability, in principle, of pharmaceutical products for purchase by United Nations agencies -- Annex 9. Guide to good storage practices for pharmaceuticals.
title_sub thirty-seventh report.
title_full WHO Expert Committee on Specifications for Pharmaceutical Preparations [electronic resource] : thirty-seventh report.
title_fullStr WHO Expert Committee on Specifications for Pharmaceutical Preparations [electronic resource] : thirty-seventh report.
title_full_unstemmed WHO Expert Committee on Specifications for Pharmaceutical Preparations [electronic resource] : thirty-seventh report.
title_auth WHO Expert Committee on Specifications for Pharmaceutical Preparations thirty-seventh report.
title_new WHO Expert Committee on Specifications for Pharmaceutical Preparations
title_sort who expert committee on specifications for pharmaceutical preparations thirty-seventh report.
series WHO technical report series,
series2 WHO technical report series,
publisher World Health Organization,
publishDate 2003
physical viii, 145 p.
contents 1. Introduction -- 2. General policy -- 3. Quality control--specifications and tests -- 4. Quality control--international reference materials -- 5. Quality control--national laboratories -- 6. Quality assurance--good manufacturing practices (GMP) -- 7. Quality assurance--inspection -- 8. Quality assurance--distribution and trade-related -- 9. Quality assurance--risk analysis -- 10. Quality assurance--drug supply -- 11. Quality assurance--storage -- 12. International Nonproprietary Names (INNs) Programme -- 13. Miscellaneous -- Annex 1. Recommendations on risk of transmitting animal spongiform encephalopathy agents via medicinal products -- Annex 2. The International Pharmacopoeia: revised concepts and future perspectives -- Annex 3. Guidelines on good manufacturing practices for radiopharmaceutical products -- Annex 4. Good manufacturing practices for pharmaceutial products: main prinicples -- Annex 5. Model certificate of good manufacturing practices -- Annex 6. Guidance on good manufacturing practices (GMP): inspection report -- Annex 7. Application of hazard analysis and critical control point (HACCP) method to pharmaceuticals -- Annex 8. Procedure for assessing the acceptability, in principle, of pharmaceutical products for purchase by United Nations agencies -- Annex 9. Guide to good storage practices for pharmaceuticals.
issn 0512-3054 ;
callnumber-first R - Medicine
callnumber-subject RA - Public Medicine
callnumber-label RA8
callnumber-sort RA 18 A247 W46 42003
genre Electronic books.
genre_facet Congresses.
Electronic books.
url https://ebookcentral.proquest.com/lib/oeawat/detail.action?docID=284793
illustrated Not Illustrated
oclc_num 191039475
work_keys_str_mv AT whoexpertcommitteeonspecificationsforpharmaceuticalpreparationsmeeting whoexpertcommitteeonspecificationsforpharmaceuticalpreparationsthirtyseventhreport
AT proquestfirm whoexpertcommitteeonspecificationsforpharmaceuticalpreparationsthirtyseventhreport
status_str n
ids_txt_mv (MiAaPQ)500284793
(Au-PeEL)EBL284793
(CaPaEBR)ebr10040297
(OCoLC)191039475
hierarchy_parent_title WHO technical report series, 908
hierarchy_sequence 908.
is_hierarchy_title WHO Expert Committee on Specifications for Pharmaceutical Preparations thirty-seventh report.
container_title WHO technical report series, 908
author2_original_writing_str_mv noLinkedField
_version_ 1792330675927384064
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02807nam a2200349Ia 4500</leader><controlfield tag="001">500284793</controlfield><controlfield tag="003">MiAaPQ</controlfield><controlfield tag="005">20200520144314.0</controlfield><controlfield tag="006">m o d | </controlfield><controlfield tag="007">cr cn|||||||||</controlfield><controlfield tag="008">030508s2003 sz s o000 0 eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">9241209089</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(MiAaPQ)500284793</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(Au-PeEL)EBL284793</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CaPaEBR)ebr10040297</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)191039475</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">MiAaPQ</subfield><subfield code="c">MiAaPQ</subfield><subfield code="d">MiAaPQ</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RA8.A247</subfield><subfield code="b">W46 2003</subfield></datafield><datafield tag="110" ind1="2" ind2=" "><subfield code="a">WHO Expert Committee on Specifications for Pharmaceutical Preparations.</subfield><subfield code="b">Meeting</subfield><subfield code="n">(37th :</subfield><subfield code="d">2001 :</subfield><subfield code="c">Geneva, Switzerland)</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">WHO Expert Committee on Specifications for Pharmaceutical Preparations</subfield><subfield code="h">[electronic resource] :</subfield><subfield code="b">thirty-seventh report.</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">Geneva :</subfield><subfield code="b">World Health Organization,</subfield><subfield code="c">2003.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">viii, 145 p.</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">WHO technical report series,</subfield><subfield code="x">0512-3054 ;</subfield><subfield code="v">908</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">1. Introduction -- 2. General policy -- 3. Quality control--specifications and tests -- 4. Quality control--international reference materials -- 5. Quality control--national laboratories -- 6. Quality assurance--good manufacturing practices (GMP) -- 7. Quality assurance--inspection -- 8. Quality assurance--distribution and trade-related -- 9. Quality assurance--risk analysis -- 10. Quality assurance--drug supply -- 11. Quality assurance--storage -- 12. International Nonproprietary Names (INNs) Programme -- 13. Miscellaneous -- Annex 1. Recommendations on risk of transmitting animal spongiform encephalopathy agents via medicinal products -- Annex 2. The International Pharmacopoeia: revised concepts and future perspectives -- Annex 3. Guidelines on good manufacturing practices for radiopharmaceutical products -- Annex 4. Good manufacturing practices for pharmaceutial products: main prinicples -- Annex 5. Model certificate of good manufacturing practices -- Annex 6. Guidance on good manufacturing practices (GMP): inspection report -- Annex 7. Application of hazard analysis and critical control point (HACCP) method to pharmaceuticals -- Annex 8. Procedure for assessing the acceptability, in principle, of pharmaceutical products for purchase by United Nations agencies -- Annex 9. Guide to good storage practices for pharmaceuticals.</subfield></datafield><datafield tag="533" ind1=" " ind2=" "><subfield code="a">Electronic reproduction. Ann Arbor, MI : ProQuest, 2015. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Drugs</subfield><subfield code="x">Standards</subfield><subfield code="v">Congresses.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Drugs</subfield><subfield code="x">Specifications</subfield><subfield code="v">Congresses.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Pharmaceutical industry</subfield><subfield code="x">Quality control</subfield><subfield code="v">Congresses.</subfield></datafield><datafield tag="655" ind1=" " ind2="4"><subfield code="a">Electronic books.</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">ProQuest (Firm)</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Technical report series (World Health Organization) ;</subfield><subfield code="v">908.</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://ebookcentral.proquest.com/lib/oeawat/detail.action?docID=284793</subfield><subfield code="z">Click to View</subfield></datafield></record></collection>